pharma-company /Medicinal products /Active ingredients

Rx · PZN 08878038

BENLYSTA 400 mg powder for preparation of a concentrate for solution for infusion

German trade nameBENLYSTA 400 mg Pulver zur Herstellung einer Infusions Lösungskonzentrat

Active ingredientBelimumab

Consistently available

8.3

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €434

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

BENLYSTA 400 mg powder for preparation of a concentrate for solution for infusion is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

BENLYSTA 400 mg powder for preparation of a concentrate for solution for infusion contains the active ingredient Belimumab. One pack size is recorded (PZN 08878038). The pharma availability index for German wholesale stands at 8.3 out of 10 over the past 30 days – the pack was therefore consistently available.


We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.